FOLH1 and cancer: The increasing evidence of cancer localizations on salivary glands with PSMA- PET/CT, encouraged some authors to explore the possible use of a palliative PSMA target therapy with 177Lu-PSMA in these kind of patients after the failure of conventional treatments (Table 1).